Modeling the pathway of breast cancer in the Middle East

[1] Rennert G.: Breast cancer, In Cancer Incidence in the Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. Volume (Chapter 8). Edited by L. S. Friedman, B. K. Edwards, L. A. G. Ries, J. L. Young. National Cancer Institute. NIH Pub No. 06-5873. Bethesda, MD;:73-81, (2006). Search in Google Scholar

[2] N. A. Lakkis, S. M. Adib, M. H. Osman, U. M. Musharafieh, and G. N. Hamadeh, Breast cancer in Lebanon: Incidence and comparison to regional and western countries, Cancer Epidemiology, vol. 34, no. 3, 221-225, (2010). Search in Google Scholar

[3] T. V. Clendenen, W. Ge, K. L. Koenig, Y. Afanasyeva, C. Agnoli, L. A. Brinton, F. Darvishian, J. F. Dorgan, A. H. Eliassen, R. T. Falk, et al., Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the gail model, Breast Cancer Research, vol. 21, no. 1, pp. 42, (2019). Search in Google Scholar

[4] A. M. Falstie-Jensen, A. Kjrsgaard, E. L. Lorenzen, J. D. Jensen, K. V. Reinertsen, O. M. Dekkers, M. Ewertz, and D. P. Cronin-Fenton, Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality-a danish population-based study, Breast Cancer Research, vol. 21, no. 1, pp. 44, (2019). Search in Google Scholar

[5] C. M. Vachon, C. G. Scott, R. M. Tamimi, D. J. Thompson, P. A. Fasching, J. Stone, M. C. Southey, S. Winham, S. Lindstrm, J. Lilyquist, et al., Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk, Breast Cancer Research, vol. 21, no. 1, pp. 68, (2019). Search in Google Scholar

[6] M. T. Grinde, B. Hilmarsdottir, H. M. Tunset, I. M. Henriksen, J. Kim, M. H. Haugen, M. B. Rye, G. M. Mlandsmo, and S. A. Moestue, Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer, Breast Cancer Research, vol. 21, no. 1, pp. 61, (2019). Search in Google Scholar

[7] R. Demicheli, H. Dillekas, O. Straume, and E. Biganzoli, Distant metastasis dynamics following sub- sequent surgeries after primary breast cancer removal, Breast Cancer Research, vol. 21, no. 1, pp. 57, (2019). Search in Google Scholar

[8] J. Santucci-Pereira, A. Zeleniuch-Jacquotte, Y. Afanasyeva, H. Zhong, M. Slifker, S. Peri, E. A. Ross, R. L. de Cicco, Y. Zhai, T. Nguyen, et al., Genomic signature of parity in the breast of premenopausal women, Breast Cancer Research, vol. 21, no. 1, pp. 46, (2019). Search in Google Scholar

[9] Y. Shieh, C. G. Scott, M. R. Jensen, A. D. Norman, K. A. Bertrand, V. S. Pankratz, K. R. Brandt, D. W. Visscher, J. A. Shepherd, R. M. Tamimi, et al., Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype, Breast Cancer Research, vol. 21, no. 1, pp. 48, (2019). Search in Google Scholar

[10] H. Samavat, X. Xun, A. Jin, R. Wang, W.-P. Koh, and J.-M. Yuan, Association between prediagnostic leukocyte telomere length and breast cancer risk: the singapore chinese health study, Breast Cancer Research, vol. 21, no. 1, pp. 50, (2019). Search in Google Scholar

[11] X. Zhang, Y. Wang, H.-C. Chiang, Y.-P. Hsieh, C. Lu, B. H. Park, I. Jatoi, V. X. Jin, Y. Hu, and R. Li, BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells, Breast Cancer Research, vol. 21, no. 1, pp. 51, (2019). Search in Google Scholar

[12] C. Petridis, I. Arora, V. Shah, A. Megalios, C. Moss, A. Mera, A. Clifford, C. Gillett, S. E. Pinder, I. Tomlinson, et al., Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years, Breast Cancer Research, vol. 21, no. 1, pp. 58, (2019). Search in Google Scholar

[13] L. Huss, S. T. Butt, S. Borgquist, K. Elebro, M. Sandsveden, A. Rosendahl, and J. Manjer, Vitamin D receptor expression in invasive breast tumors and breast cancer survival, Breast Cancer Research, vol. 21, no. 1, pp. 84, (2019). Search in Google Scholar

[14] E. Linnenbringer, S. Gehlert, and A. T. Geronimus, Black-white disparities in breast cancer subtype: the intersection of socially patterned stress and genetic expression, AIMS public health, vol. 4, no. 5, pp. 526, (2017). Search in Google Scholar

[15] X. Nian, Y. Nagai, C. Jeffers, K. N. Maxwell, and H. Zhang, Dietary influence on estrogens and cytokines in breast cancer, AIMS MOLECULAR SCIENCE, vol. 4, no. 3, pp. 252-270, (2017). Search in Google Scholar

[16] A. S. Kashani and M. Packirisamy, Cellular deformation characterization of human breast cancer cells under hydrodynamic forces, AIMS Biophysics, vol. 4, pp. 400-414, (2017). Search in Google Scholar

[17] H.-C. Wei, Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line, Mathematical Biosciences and Engineering, vol. 16, no. 6, pp. 6512-6535, (2019). Search in Google Scholar

[18] D. M. Parkin and L. M. Fernandez, Use of statistics to assess the global burden of breast cancer, The breast journal, vol. 12, pp. S70-S80, (2006). Search in Google Scholar

[19] D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, 2002, CA: a cancer journal for clinicians, vol. 55, no. 2, pp. 74-108, (2005). Search in Google Scholar

[20] B. O. Anderson, C.-H. Yip, S. D. Ramsey, R. Bengoa, S. Braun, M. Fitch, M. Groot, H. Sancho-Garnier, V. D. Tsu, G. S. H. C. Systems, and P. P. Panel, Breast cancer in limited-resource countries: health care systems and public policy, The breast journal, vol. 12, pp. S54-S69, (2006). Search in Google Scholar

[21] F. Bray, P. McCarron, and D. M. Parkin, The changing global patterns of female breast cancer incidence and mortality, Breast cancer research, vol. 6, no. 6, p. 229, (2004). Search in Google Scholar

[22] S. M. Mousavi, A. Montazeri, M. A. Mohagheghi, A. M. Jarrahi, I. Harirchi, M. Najafi, M. Ebrahimi, Breast Cancer in Iran: an epidemiological review, The breast journal, vol. 13, no. 4, 383-391, (2007). Search in Google Scholar

[23] I. G. Alghamdi, I. I. Hussain, M. S. Alghamdi, M. A. El-Sheemy, The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi cancer registry 2001-2008, Breast Cancer: Targets and Therapy, vol. 5, 103-109, (2013). Search in Google Scholar

[24] V. Ozmen, B. Ozcina, H. Karanlik, et al., Breast cancer risk factors in Turkish women-a university hospital based nested case control study, World Journal of Surgical Oncology, vol. 7, no.1, 37, (2009). Search in Google Scholar

[25] N. S. El Saghir, M. K. Kahlil, T. Eid, et al., Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis, International journal of surgery, vol. 5, no.4, 225-233, (2007). Search in Google Scholar

[26] M. Corbex, S. Bouzbid, P. Boffetta, Features of breast cancer in developing countries, examples from North-Africa, European Journal of Cancer, vol. 50, no.10, 1808-1818, (2014). Search in Google Scholar

[27] K. A. Hirko, A. S. Soliman, A. Hablas, et al., Trends in breast cancer incidence rates by age and stage at diagnosis in Gharbiah, Egypt over 10 years (1999-2008), Journal of cancer epidemiology, vol. 2013, Article ID 916394, 7 pages, (2013). Search in Google Scholar

[28] D. M. McCredie, M. Coates, A. Grulich, Cancer incidence in migrants to new South Wales (Australia) from the Middle East 1972-91, Cancer Causes & Control, vol. 5, no. 5, 414-421, (1994). Search in Google Scholar

[29] S. A. M. Karim, H. H. A. Ghalib, S. A. Mohammed, and F. H. R. Fattah, The incidence, age at diagnosis of breast cancer in the iraqi kurdish population and comparison to some other countries of middle-east and west, International Journal of Surgery, vol. 13, pp. 71-75, (2015). Search in Google Scholar

[30] D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol. 144, no. 5, pp. 646-674, (2011). Search in Google Scholar

[31] L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, et al., The genomic landscapes of human breast and colorectal cancers, Science, vol. 318, no. 5853, pp. 1108-1113, (2007). Search in Google Scholar

[32] S.H. Moolgavkar, A.G. Knudson, Mutation and cancer: a model for human carsinogenosis, JNCI: Journal of the National Cancer Institute, vol. 66, no.6, 1037-1052, (1981). Search in Google Scholar

[33] S. H. Moolgavkar, A. Dewanji, D. J. Venzon, A stochastic two-stage model for cancer risk assessment. I. the hazard function and the probability of tumor, Risk Analysis, vol. 8, no.3, 383-392, (1988). Search in Google Scholar

[34] E. G. Luebeck, S. H. Moolgavkar, Multistage carcinogenesis and the incidence of colorectal cancer, Proceedings of the National Academy of Sciences, vol. 99, no. 23, 15095-15100, (2002). Search in Google Scholar

[35] X. Zhang and R. Simon, Estimating the number of rate limiting genomic changes for human breast cancer, Breast cancer research and treatment, vol. 91, no. 2, pp. 121-124, (2005). Search in Google Scholar

[36] X. Zhang, Y. Fang, Y. Zhao, and W. Zheng, Mathematical modeling the pathway of human breast cancer, Mathematical biosciences, vol. 253, pp. 25-29, (2014). Search in Google Scholar

[37] L. Li, T. Tian, and X. Zhang, Mutation mechanisms of human breast cancer, Journal of Computational Biology, vol. 25, no. 4, pp. 396-404, (2018). Search in Google Scholar

[38] L. A. G. Ries, M. P. Eisner, C. L. Kosary, et al. SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD, (2002). Search in Google Scholar

[39] A. S. Ibrahim, H. M. Khaled, N. N. Mikhail, H. Baraka, and H. Kamel, Cancer incidence in Egypt: results of the national population-based cancer registry program, Journal of cancer epidemiology, vol. 2014, Article ID 437971, 18 pages, (2014). Search in Google Scholar

[40] M. E. C. Consortium et al., Manual of standards for cancer registration. 2005, Available at: http://mecc.cancer.gov/MECCManualofStandards.PDF. [Last Accessed: 1/06]. Search in Google Scholar

[41] N. T. J. Bailey, The Elements of Stochastic Processes (Wiley, New York), (1964). Modeling the pathway of breast cancer in the Middle East 165 Search in Google Scholar

[42] C. L. Chiang, Introduction to Stochastic Processes in Biostatistics (Wiley, New York), (1968). Search in Google Scholar

[43] G. Serio, Two-stage stochastic model for carcinogenesis with time-dependent parameters, Statistics & probability letters, vol. 2, no. 2, pp. 95-103, (1984). Search in Google Scholar

[44] C. J. Portier, A. Kopp-Schneider, and C. D. Sherman, Calculating tumor incidence rates in stochastic models of carcinogenesis, Mathematical biosciences, vol. 135, no. 2, pp. 129-146, (1996). Search in Google Scholar

[45] L. A. Loeb, Human cancers express a mutator phenotype: hypothesis, origin, and consequences, Cancer research, vol. 76, no. 8, pp. 2057-2059, (2016). Search in Google Scholar